Literature DB >> 33668766

Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study.

Claudia Josa-Laorden1,2, Anxela Crestelo-Vieitez1, María Del Mar García Andreu1, Manuel Rubio-Rivas3, Marcos Sánchez4, Neera Toledo Samaniego5, Francisco Arnalich Fernández6, Rosario Iguaran Bermudez7, Eva Ma Fonseca Aizpuru8, Juan Antonio Vargas Núñez9, Paula Maria Pesqueira Fontan10, Jorge Serrano Ballesteros11, Santiago Jesús Freire Castro12, Melani Pestaña Fernández13, Alba Viana García14, Victoria Nuñez Rodriguez15, Vicente Giner-Galvañ16,17, Francisco Javier Carrasco Sánchez18, Almudena Hernández Milián19, Marta Cobos-Siles20, Jose Javier Napal Lecumberri21, Virginia Herrero García22, Maria de Los Reyes Pascual Pérez23, Jesús Millán Núñez-Cortés5, José Manuel Casas Rojo24.   

Abstract

There is some evidence that male gender could have a negative impact on the prognosis and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of the present study was to compare the characteristics of coronavirus disease 2019 (COVID-19) between hospitalized men and women with confirmed SARS-CoV-2 infection. This multicenter, retrospective, observational study is based on the SEMI-COVID-19 Registry. We analyzed the differences between men and women for a wide variety of demographic, clinical, and treatment variables, and the sex distribution of the reported COVID-19 deaths, as well as intensive care unit (ICU) admission by age subgroups. This work analyzed 12,063 patients (56.8% men). The women in our study were older than the men, on average (67.9 vs. 65.7 years; p < 001). Bilateral condensation was more frequent among men than women (31.8% vs. 29.9%; p = 0.007). The men needed non-invasive and invasive mechanical ventilation more frequently (5.6% vs. 3.6%, p < 0.001, and 7.9% vs. 4.8%, p < 0.001, respectively). The most prevalent complication was acute respiratory distress syndrome, with severe cases in 19.9% of men (p < 0.001). In men, intensive care unit admission was more frequent (10% vs. 6.1%; p < 0.001) and the mortality rate was higher (23.1% vs. 18.9%; p < 0.001). Regarding mortality, the differences by gender were statistically significant in the age groups from 55 years to 89 years of age. A multivariate analysis showed that female sex was significantly and independently associated with a lower risk of mortality in our study. Male sex appears to be related to worse progress in COVID-19 patients and is an independent prognostic factor for mortality. In order to fully understand its prognostic impact, other factors associated with sex must be considered.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; Spain; coronavirus; gender differences

Year:  2021        PMID: 33668766     DOI: 10.3390/jcm10050899

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  7 in total

1.  Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients.

Authors:  Vincenzo Russo; Roberta Bottino; Antonello D'Andrea; Angelo Silverio; Marco Di Maio; Paolo Golino; Gerardo Nigro; Orazio Valsecchi; Emilio Attena; Mario Enrico Canonico; Gennaro Galasso; Guido Parodi; Fernando Scudiero
Journal:  Cardiovasc Drugs Ther       Date:  2021-05-14       Impact factor: 3.947

2.  Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkers.

Authors:  Maria Teresa Pagano; Daniela Peruzzu; Luca Busani; Marina Pierdominici; Anna Ruggieri; Andrea Antinori; Gianpiero D'Offizi; Nicola Petrosillo; Fabrizio Palmieri; Pierluca Piselli; Stefania Cicalini; Stefania Notari; Emanuele Nicastri; Chiara Agrati; Giuseppe Ippolito; Francesco Vaia; Maria Cristina Gagliardi; Maria Rosaria Capobianchi; Elena Ortona
Journal:  Biol Sex Differ       Date:  2021-11-22       Impact factor: 5.027

3.  An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution.

Authors:  Francisco Javier Gil-Etayo; Sara Garcinuño; Alberto Utrero-Rico; Oscar Cabrera-Marante; Daniel Arroyo-Sanchez; Esther Mancebo; Daniel Enrique Pleguezuelo; Edgard Rodríguez-Frías; Luis M Allende; Pablo Morales-Pérez; María José Castro-Panete; Antonio Lalueza; Carlos Lumbreras; Estela Paz-Artal; Antonio Serrano
Journal:  Biomedicines       Date:  2022-01-27

4.  Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19.

Authors:  Francisco Javier Redondo-Calvo; Juan Fernando Padín; José Ramón Muñoz-Rodríguez; Leticia Serrano-Oviedo; Pilar López-Juárez; María Lourdes Porras Leal; Francisco Javier González Gasca; Marta Rodríguez Martínez; Raúl Pérez Serrano; Abraham Sánchez Cadena; Natalia Bejarano-Ramírez; Constanza Muñoz Hornero; José Ramón Barberá Farré; Inmaculada Domínguez-Quesada; María A Sepúlveda Berrocal; María Dolores Villegas Fernández-Infantes; María Isabel Manrique Romo; Ángel Parra Comino; José Manuel Pérez-Ortiz; Francisco Javier Gómez-Romero
Journal:  Eur J Clin Invest       Date:  2022-04-05       Impact factor: 5.722

5.  Sex Differences and Predictors of In-Hospital Mortality among Patients with COVID-19: Results from the ANCOHVID Multicentre Study.

Authors:  Nicolás Francisco Fernández-Martínez; Rocío Ortiz-González-Serna; Álvaro Serrano-Ortiz; Mario Rivera-Izquierdo; Rafael Ruiz-Montero; Marina Pérez-Contreras; Inmaculada Guerrero-Fernández de Alba; Álvaro Romero-Duarte; Inmaculada Salcedo-Leal
Journal:  Int J Environ Res Public Health       Date:  2021-08-26       Impact factor: 3.390

6.  Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients.

Authors:  Yasutaka Mitamura; Daniel Schulz; Saskia Oro; Nick Li; Isabel Kolm; Claudia Lang; Reihane Ziadlou; Ge Tan; Bernd Bodenmiller; Peter Steiger; Angelo Marzano; Nicolas de Prost; Olivier Caudin; Mitchell Levesque; Corinne Stoffel; Peter Schmid-Grendelmeier; Emanual Maverakis; Cezmi A Akdis; Marie-Charlotte Brüggen
Journal:  Allergy       Date:  2021-07-19       Impact factor: 14.710

7.  Application of CALL score for prediction of progression risk in patients with COVID-19 at university hospital in Turkey.

Authors:  Buket Erturk Sengel; Elif Tukenmez Tigen; Can Ilgin; Tugce Basari; Merve Bedir; Zekaver Odabasi; Volkan Korten
Journal:  Int J Clin Pract       Date:  2021-08-04       Impact factor: 3.149

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.